Our preliminary research findings report a significant reduction in TRPM3 surface expression for B lymphocytes and CD56Bright cells from CFS/ME patients compared with healthy controls. The gene discussed is TRPM3; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.